Long-term local control and survival after preoperative radiochemotherapy in combination with deep regional hyperthermia in locally advanced rectal cancer

Int J Hyperthermia. 2016;32(2):187-92. doi: 10.3109/02656736.2015.1117661. Epub 2016 Jan 11.

Abstract

Purpose: The aim of this study was to evaluate the impact of deep regional hyperthermia on long-term local control and survival in locally advanced non-metastatic rectal cancer.

Methods: In total 103 patients with locally advanced non-metastatic rectal cancer were treated preoperatively with either neoadjuvant radiochemotherapy alone (n = 43) or the same treatment with additional deep regional hyperthermia (n = 60). The two groups were compared with respect to local control, overall survival (OS), disease-free survival (DFS), and distant metastases-free survival (DMFS).

Results: Patients receiving additional hyperthermia had excellent long-term local control with a 5-year Kaplan-Meier estimate of 98% compared with 87% in the radiochemotherapy only group (p = 0.09). Five-year rates for OS (88% versus 76%, p = 0.08), DFS (77% versus 73%, p = n.s.) and DMFS (75% versus 77%, p = n.s.) were not statistically different between the two groups.

Conclusion: Radiochemotherapy combined with hyperthermia results in excellent long-term local control.

Keywords: Chemoradiotherapy; disease-free survival; hyperthermia; local control; overall survival; radiochemotherapy; rectal cancer.

MeSH terms

  • Adenocarcinoma / therapy*
  • Adult
  • Aged
  • Aged, 80 and over
  • Chemoradiotherapy*
  • Disease-Free Survival
  • Female
  • Humans
  • Hyperthermia, Induced*
  • Kaplan-Meier Estimate
  • Male
  • Middle Aged
  • Rectal Neoplasms / therapy*